Matt Roache | Director of Investor Relations |
Tom McCourt | Chief Executive Officer |
Mike Shetzline | Chief Medical Officer |
Jason Rickard | Chief Operating Officer |
Hannah Adeoye | JPMorgan |
David Lebowitz | Morgan Stanley |
Tim Chiang | Northland Capital |
Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Third Quarter 2021 Investor Update Call. All lines have been placed on mute to prevent any background noise. After the speaker’s presentation, there will be a question-and-answer session.